| 000 | 01711 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250517221841.0 | ||
| 264 | 0 | _c20190715 | |
| 008 | 201907s 0 0 eng d | ||
| 022 | _a1528-0020 | ||
| 024 | 7 |
_a10.1182/blood-2018-03-840348 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHuet, Sarah | |
| 245 | 0 | 0 |
_aValidation of the prognostic value of the knowledge bank approach to determine AML prognosis in real life. _h[electronic resource] |
| 260 |
_bBlood _c08 2018 |
||
| 300 |
_a865-867 p. _bdigital |
||
| 500 | _aPublication Type: Letter; Validation Study | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAnthracyclines _xadministration & dosage |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadministration & dosage |
| 650 | 0 | 4 |
_aCytarabine _xadministration & dosage |
| 650 | 0 | 4 | _aDatabases, Factual |
| 650 | 0 | 4 | _aDisease-Free Survival |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLeukemia, Myeloid, Acute _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPredictive Value of Tests |
| 650 | 0 | 4 | _aSurvival Rate |
| 700 | 1 | _aPaubelle, Etienne | |
| 700 | 1 | _aLours, Camille | |
| 700 | 1 | _aGrange, Beatrice | |
| 700 | 1 | _aCourtois, Lucien | |
| 700 | 1 | _aChabane, Kaddour | |
| 700 | 1 | _aCharlot, Carole | |
| 700 | 1 | _aMosnier, Isabelle | |
| 700 | 1 | _aSimonet, Thomas | |
| 700 | 1 | _aHayette, Sandrine | |
| 700 | 1 | _aTigaud, Isabelle | |
| 700 | 1 | _aThomas, Xavier | |
| 700 | 1 | _aSalles, Gilles | |
| 700 | 1 | _aSubtil, Fabien | |
| 700 | 1 | _aSujobert, Pierre | |
| 773 | 0 |
_tBlood _gvol. 132 _gno. 8 _gp. 865-867 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1182/blood-2018-03-840348 _zAvailable from publisher's website |
| 999 |
_c28495298 _d28495298 |
||